- Home
- NGD vs MMSI Comparison
NGD vs MMSI Comparison
Compare NGD & MMSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | NGD | MMSI |
|---|---|---|
| Founded | N/A | 1987 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | | Medical/Dental Instruments |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.3B | 4.8B |
| IPO Year | 2004 | 1990 |
Fundamental Metrics
Financial Performance| Metric | NGD | MMSI |
|---|---|---|
| Price | $8.85 | $88.57 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 2 | 8 |
| Target Price | $8.75 | ★ $106.13 |
| AVG Volume (30 Days) | ★ 16.1M | 596.0K |
| Earning Date | 02-18-2026 | 10-30-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 1232.42 | N/A |
| EPS | 0.31 | ★ 1.95 |
| Revenue | $1,242,200,000.00 | ★ $1,477,128,000.00 |
| Revenue This Year | $62.14 | $13.53 |
| Revenue Next Year | $57.44 | $6.30 |
| P/E Ratio | ★ $28.22 | $45.21 |
| Revenue Growth | ★ 44.19 | 11.41 |
| 52 Week Low | $2.43 | $78.12 |
| 52 Week High | $9.59 | $111.45 |
Technical Indicators
Market Signals| Indicator | NGD | MMSI |
|---|---|---|
| Relative Strength Index (RSI) | 59.80 | 62.88 |
| Support Level | $8.68 | $86.87 |
| Resistance Level | $9.52 | $88.97 |
| Average True Range (ATR) | 0.51 | 1.56 |
| MACD | 0.03 | 0.19 |
| Stochastic Oscillator | 64.16 | 82.22 |
Price Performance
Historical ComparisonAbout NGD New Gold Inc.
New Gold Inc participates in the development and operation of intermediate mining properties. The company has a portfolio of two primary assets which are also its operating segments: the Rainy River Mine and the New Afton Mine in Canada. The company also owns the Cerro San Pedro Mine in Mexico. The company derives revenue from the sale of gold, copper, and silver.
About MMSI Merit Medical Systems Inc.
Merit Medical Systems Inc is a medical equipment company that develops and manufactures products for interventional cardiology, radiology, and endoscopy procedures. The firm reports two segments which are Cardiovascular and Endoscopy. The majority of the revenue is earned from the Cardiovascular segment which consists of cardiology and radiology medical device products that assist in diagnosing and treating coronary artery disease, peripheral vascular disease, and other non-vascular diseases and includes embolotherapeutic, cardiac rhythm management, electrophysiology, critical care, and interventional oncology and spine devices.